SK bioscience : Interim Report on Business Performance (Fair Disclosure)

Interim Report on Business Performance (Fair Disclosure)

※ The following are interim figures, and may be different from final data.
1. Details of business performance	in KRW mn, %
Category	Current period	Previous period	Changes over previous period (%)	Same period of last year	Changes over same period of last year (%)
('22.1Q )	('21.4Q )	('21.1Q)
Sales	Current	87,091	450,858	-80.7	112,710	-22.7
Cumulative	87,091	929,001	-	112,710	-22.7
Operating income	Current	23,752	253,944	-90.6	53,715	-55.8
Cumulative	23,752	474,220	-	53,715	-55.8
Net income from continuing operation before income tax	Current	32,757	251,622	-87.0	55,042	-40.5
Cumulative	32,757	471,128	-	55,042	-40.5
Net income	Current	27,806	183,966	-84.9	41,925	-33.7
Cumulative	27,806	355,139	-	41,925	-33.7
-	-	-	-	-	-
2. Details of information released	Information provider	IR Department
Information recipients	Domestic and foreign investors, media, etc.
Date & time of information released	April 29 (Fri) 4:00PM
Title and place of event held	Investor Relations Event (Conference call)
3. Contact points (department/phone number)	IR Department / 02-2008-2136
4. Other matters to be factored into investment decisions
- The performance results above are interim results on a separate basis prepared in accordance with Korean International Financial Reporting Standards (K-IFRS). - The performance results above are subject to change depending on the external auditor's accounting review.
※ Related disclosure	-